找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends; Mark A. Giembycz,Brian J. O’Connor Book 2000 Springer Basel AG 2000 Atm

[復(fù)制鏈接]
樓主: 決絕
31#
發(fā)表于 2025-3-26 22:04:06 | 只看該作者
,Grenzf?lle der Functionen ?, and ?,,a high level of reliability and accuracy, be safe, acceptable to the patient, easy to perform and non-invasive. The latter demands that the technique should not break the skin or the lining epithelium and should be devoid of effects on the tissues of the body by the dissipation of energy or the intr
32#
發(fā)表于 2025-3-27 04:57:24 | 只看該作者
https://doi.org/10.1007/978-3-662-25776-0s obtained through controlled clinical trials in patients of a similar age and disease severity as the group in which the drug is being considered for use. Abundant, high quality clinical efficacy and safety data have been obtained on the use of inhaled corticosteroids in children >3 years of age wi
33#
發(fā)表于 2025-3-27 09:14:10 | 只看該作者
Wilhelm Magnus,Fritz Oberhettingerrted the benefits of oral cortisone on ragweed pollen-induced hay fever and asthma. This was followed by a report by Gelfand [2], demonstrating clinical benefit from inhaled cortisone in a small group of patients with both allergic or non-allergic asthma. Subsequently, a multicenter trial run by the
34#
發(fā)表于 2025-3-27 12:10:55 | 只看該作者
35#
發(fā)表于 2025-3-27 15:00:16 | 只看該作者
36#
發(fā)表于 2025-3-27 19:24:51 | 只看該作者
37#
發(fā)表于 2025-3-28 00:11:27 | 只看該作者
978-3-0348-9585-9Springer Basel AG 2000
38#
發(fā)表于 2025-3-28 03:37:37 | 只看該作者
39#
發(fā)表于 2025-3-28 07:46:26 | 只看該作者
40#
發(fā)表于 2025-3-28 14:12:21 | 只看該作者
,Is Chronic Use of β2-Agonists Detrimental in the Treatment of Asthma?,enging the wisdom of regular use of the short-acting β.-agonists which traditionally have formed the mainstay of treatment for bronchial asthma [1–5]. Although all national and international guidelines for the management of asthma now rec-ommend anti-inflammatory therapy for most patients with chron
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-23 07:34
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
巴里| 舞阳县| 谷城县| 永昌县| 大悟县| 南汇区| 皋兰县| 昆明市| 靖宇县| 绥芬河市| 龙海市| 金乡县| 饶河县| 石景山区| 十堰市| 健康| 新昌县| 娄底市| 藁城市| 玉溪市| 萍乡市| 望都县| 彭水| 安阳市| 榆社县| 建湖县| 耿马| 彩票| 华容县| 南皮县| 湟中县| 开化县| 新邵县| 穆棱市| 喜德县| 沙田区| 山丹县| 大新县| 石嘴山市| 分宜县| 灵石县|